Table 2.

Quality assessment of the included studies (case reports excluded). For each included study, the Risk of Bias score and Quality assessment is reported, according to [16,17].

	Drug	Selection	Comparability	Exposure (Case Control)/Outcome (Cohort)	Quality
Spettigue et al., 2018 [20]	Olanzapine	3		2	Poor
Norris et al., 2011 [21]	Olanzapine	3	2	2	Good
Leggero et al., 2010 [22]	Olanzapine	2		1	Poor
Rossi et al., 2007 [45]	Haloperidol, risperidone, olanzapine	2		1	Poor
Frank et al., 2017 [39]	Aripiprazole	4	2	1	Poor
Pruccoli et al., 2022 [24]	Olanzapine	2	2	2	Fair
Tahıllıoğlu et al., 2020 [40]	Aripiprazole	1		2	Poor